EG25619A - New process for the synthesis of 1,3,4,5-tetrahydro-2H-3-benzazepin-2-one compounds and application in the synthesis of iv abradine and addition saltsthereof wwith a pharmaceutically acceptable acid - Google Patents

New process for the synthesis of 1,3,4,5-tetrahydro-2H-3-benzazepin-2-one compounds and application in the synthesis of iv abradine and addition saltsthereof wwith a pharmaceutically acceptable acid

Info

Publication number: EG25619A
Authority: EG; Egypt
Prior art keywords: synthesis; abradine; wwith; benzazepin; tetrahydro
Prior art date: 2004-04-13

Application number

EG2005020086A

Other languages

English (en)

Inventor

Jean-Michel Lerestif

Jean-Pierre Lecouve

Jean-Claude Souvie

Daniel Brigot

Original Assignee

Servier Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-04-13

Filing date

2005-02-19

Publication date

2012-03-26

2005-02-19 Application filed by Servier Lab filed Critical Servier Lab

2012-03-26 Application granted granted Critical

2012-03-26 Publication of EG25619A publication Critical patent/EG25619A/xx

Links

230000015572 biosynthetic process Effects 0.000 title 2
238000003786 synthesis reaction Methods 0.000 title 2
GYIYVTGAOWHWRI-UHFFFAOYSA-N 1,2,3,5-tetrahydro-3-benzazepin-4-one Chemical class C1CNC(=O)CC2=CC=CC=C21 GYIYVTGAOWHWRI-UHFFFAOYSA-N 0.000 title 1
239000002253 acid Substances 0.000 title 1
238000000034 method Methods 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

EG2005020086A 2004-04-13 2005-02-19 New process for the synthesis of 1,3,4,5-tetrahydro-2H-3-benzazepin-2-one compounds and application in the synthesis of iv abradine and addition saltsthereof wwith a pharmaceutically acceptable acid EG25619A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0403828A FR2868775B1 (fr)	2004-04-13	2004-04-13	Nouveau procede de synthese de derives de la 1,3,4,5- tetrahydro-2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable

Publications (1)

Publication Number	Publication Date
EG25619A true EG25619A (en)	2012-03-26

Family

ID=34941961

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EG2005020086A EG25619A (en)	2004-04-13	2005-02-19	New process for the synthesis of 1,3,4,5-tetrahydro-2H-3-benzazepin-2-one compounds and application in the synthesis of iv abradine and addition saltsthereof wwith a pharmaceutically acceptable acid

Country Status (32)

Country	Link
US (1)	US7064200B2 (de)
EP (1)	EP1614687B1 (de)
JP (2)	JP4515933B2 (de)
KR (1)	KR100636499B1 (de)
CN (1)	CN100348585C (de)
AR (1)	AR047707A1 (de)
AT (1)	ATE448221T1 (de)
AU (1)	AU2005200884B2 (de)
BR (1)	BRPI0500590B8 (de)
CA (1)	CA2496712C (de)
CY (1)	CY1109740T1 (de)
DE (1)	DE602005017541D1 (de)
DK (1)	DK1614687T3 (de)
EA (1)	EA007743B1 (de)
EG (1)	EG25619A (de)
ES (1)	ES2336461T3 (de)
FR (1)	FR2868775B1 (de)
GE (1)	GEP20074136B (de)
HR (1)	HRP20100024T1 (de)
MA (1)	MA27598A1 (de)
MX (1)	MXPA05003696A (de)
MY (1)	MY140904A (de)
NO (1)	NO329861B1 (de)
NZ (1)	NZ538328A (de)
PL (1)	PL1614687T3 (de)
PT (1)	PT1614687E (de)
RS (1)	RS51232B (de)
SG (1)	SG116574A1 (de)
SI (1)	SI1614687T1 (de)
UA (1)	UA81773C2 (de)
WO (1)	WO2005111027A1 (de)
ZA (1)	ZA200501468B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2868775B1 (fr) *	2004-04-13	2008-04-11	Servier Lab	Nouveau procede de synthese de derives de la 1,3,4,5- tetrahydro-2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2868777B1 (fr) *	2004-04-13	2006-05-26	Servier Lab	Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
GT200500185A (es) *	2004-08-09	2006-04-10		Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos
KR101478855B1 (ko)	2007-05-30	2015-01-02	인드-스위프트 래버러토리즈 리미티드	이바브라딘 히드로클로라이드 및 그의 다형태의 제조방법
EP2367782B1 (de)	2008-12-22	2013-02-13	KRKA, D.D., Novo Mesto	Verfahren zur herstellung von ivabradin
FR2940287B1 (fr) *	2008-12-24	2010-12-24	Servier Lab	Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable.
SI23290A (sl)	2010-02-12	2011-08-31	Krka D.D., Novo Mesto	Nove oblike ivabradin hidroklorida
FR2956401B1 (fr) *	2010-02-17	2012-02-03	Servier Lab	Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2971507B1 (fr) *	2011-02-14	2013-01-18	Servier Lab	Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2984320B1 (fr) *	2011-12-20	2013-11-29	Servier Lab	Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2993561B1 (fr) *	2012-07-17	2014-10-31	Servier Lab	Procede de synthese enzymatique de la (7s)-1-(3,4-dimethoxy bicyclo[4.2.0]octa-1,3,5-triene 7-yl) n-methyl methanamine, et application a la synthese de l'ivabradine et de ses sels
FR3003859B1 (fr) *	2013-03-26	2015-03-13	Servier Lab	"procede de synthese de derives de la 7,8-dimethoxy-1,3-dihydro-2h-3-benzazepin-2-one et application a la synthese de l'ivabradine"

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3119874A1 (de) *	1981-05-19	1982-12-09	Dr. Karl Thomae Gmbh, 7950 Biberach	"benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
DE3418270A1 (de) *	1984-05-17	1985-11-21	Dr. Karl Thomae Gmbh, 7950 Biberach	Neue aminotetralinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
EP0204349A3 (de)	1985-06-01	1990-01-03	Dr. Karl Thomae GmbH	Neue heteroaromatische Aminderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE3519735A1 (de) *	1985-06-01	1986-12-04	Dr. Karl Thomae Gmbh, 7950 Biberach	Neue heteroaromatische aminderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
FR2681862B1 (fr) *	1991-09-27	1993-11-12	Adir Cie	Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
FR2868775B1 (fr) *	2004-04-13	2008-04-11	Servier Lab	Nouveau procede de synthese de derives de la 1,3,4,5- tetrahydro-2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2868777B1 (fr) *	2004-04-13	2006-05-26	Servier Lab	Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable

2004
- 2004-04-13 FR FR0403828A patent/FR2868775B1/fr not_active Expired - Fee Related
2005
- 2005-02-07 CA CA2496712A patent/CA2496712C/fr not_active Expired - Lifetime
- 2005-02-15 SG SG200500770A patent/SG116574A1/en unknown
- 2005-02-17 US US11/060,043 patent/US7064200B2/en not_active Expired - Lifetime
- 2005-02-18 NO NO20050888A patent/NO329861B1/no unknown
- 2005-02-18 BR BRPI0500590A patent/BRPI0500590B8/pt not_active IP Right Cessation
- 2005-02-18 NZ NZ538328A patent/NZ538328A/en not_active IP Right Cessation
- 2005-02-18 AU AU2005200884A patent/AU2005200884B2/en not_active Expired
- 2005-02-18 MY MYPI20050621A patent/MY140904A/en unknown
- 2005-02-18 AR ARP050100586A patent/AR047707A1/es active IP Right Grant
- 2005-02-18 CN CNB2005100542167A patent/CN100348585C/zh not_active Expired - Lifetime
- 2005-02-18 ZA ZA2005/01468A patent/ZA200501468B/en unknown
- 2005-02-18 MA MA28112A patent/MA27598A1/fr unknown
- 2005-02-18 GE GEAP8647A patent/GEP20074136B/en unknown
- 2005-02-18 UA UAA200501524A patent/UA81773C2/uk unknown
- 2005-02-18 JP JP2005041810A patent/JP4515933B2/ja not_active Expired - Lifetime
- 2005-02-19 KR KR1020050013860A patent/KR100636499B1/ko not_active Expired - Lifetime
- 2005-02-19 EG EG2005020086A patent/EG25619A/xx active
- 2005-02-21 EA EA200500240A patent/EA007743B1/ru unknown
- 2005-02-21 EP EP05290383A patent/EP1614687B1/de not_active Expired - Lifetime
- 2005-02-21 PT PT05290383T patent/PT1614687E/pt unknown
- 2005-02-21 DE DE602005017541T patent/DE602005017541D1/de not_active Expired - Lifetime
- 2005-02-21 DK DK05290383.8T patent/DK1614687T3/da active
- 2005-02-21 RS RSP-2010/0006A patent/RS51232B/sr unknown
- 2005-02-21 AT AT05290383T patent/ATE448221T1/de active
- 2005-02-21 PL PL05290383T patent/PL1614687T3/pl unknown
- 2005-02-21 SI SI200530864T patent/SI1614687T1/sl unknown
- 2005-02-21 ES ES05290383T patent/ES2336461T3/es not_active Expired - Lifetime
- 2005-02-21 WO PCT/FR2005/000396 patent/WO2005111027A1/fr not_active Ceased
- 2005-04-07 MX MXPA05003696A patent/MXPA05003696A/es active IP Right Grant
2009
- 2009-09-25 JP JP2009220529A patent/JP5277130B2/ja not_active Expired - Lifetime
2010
- 2010-01-13 HR HR20100024T patent/HRP20100024T1/hr unknown
- 2010-01-19 CY CY20101100053T patent/CY1109740T1/el unknown

Also Published As

Publication number	Publication date
MA27598A1 (fr)	2005-11-01
AR047707A1 (es)	2006-02-08
ATE448221T1 (de)	2009-11-15
JP2005298478A (ja)	2005-10-27
RS51232B (sr)	2010-12-31
EP1614687A1 (de)	2006-01-11
WO2005111027A1 (fr)	2005-11-24
UA81773C2 (uk)	2008-02-11
EA200500240A1 (ru)	2005-10-27
JP5277130B2 (ja)	2013-08-28
US7064200B2 (en)	2006-06-20
CY1109740T1 (el)	2014-09-10
JP4515933B2 (ja)	2010-08-04
CA2496712C (fr)	2010-04-06
ES2336461T3 (es)	2010-04-13
PL1614687T3 (pl)	2010-04-30
SI1614687T1 (sl)	2010-01-29
GEP20074136B (en)	2007-06-25
PT1614687E (pt)	2009-12-02
US20050228178A1 (en)	2005-10-13
ZA200501468B (en)	2005-11-30
DE602005017541D1 (de)	2009-12-24
NZ538328A (en)	2005-10-28
EA007743B1 (ru)	2006-12-29
NO20050888L (no)	2005-10-14
BRPI0500590B1 (pt)	2018-10-09
BRPI0500590A (pt)	2005-11-16
MY140904A (en)	2010-01-29
MXPA05003696A (es)	2006-01-24
HK1079777A1 (zh)	2006-04-13
KR20060042117A (ko)	2006-05-12
NO20050888D0 (no)	2005-02-18
EP1614687B1 (de)	2009-11-11
JP2010047577A (ja)	2010-03-04
DK1614687T3 (da)	2010-03-29
CN100348585C (zh)	2007-11-14
BRPI0500590B8 (pt)	2021-05-25
KR100636499B1 (ko)	2006-10-18
AU2005200884B2 (en)	2010-07-15
SG116574A1 (en)	2005-11-28
CA2496712A1 (fr)	2005-10-13
NO329861B1 (no)	2011-01-17
FR2868775A1 (fr)	2005-10-14
HRP20100024T1 (hr)	2010-02-28
CN1683343A (zh)	2005-10-19
AU2005200884A1 (en)	2005-10-27
FR2868775B1 (fr)	2008-04-11

Publication	Publication Date	Title
AP1821A (en)	2008-01-21	New process for the synthesis of ivabradine and additional salts thereof with a pharmaceutically acceptable acid
EG23719A (en)	2007-06-17	New process for the synthesis of (I S)-4,5-dimethoxy-1-(methylaminomethyl)-benzocyclobutane and addition salts thereof, and application in the synthesis of I V abradine and addition salts thereof witha pharmaceutically acceptable acid
PT2272824T (pt)	2017-11-15	Processo para a produção de 2,4¿-metilenodifenildiisocianato muito puro
IL181766A0 (en)	2007-07-04	A process for the preparation of [1,4,5]-oxadiazepine derivatives
ZA200904316B (en)	2010-05-26	Process for the synthesis of 7,8-dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
EG25619A (en)	2012-03-26	New process for the synthesis of 1,3,4,5-tetrahydro-2H-3-benzazepin-2-one compounds and application in the synthesis of iv abradine and addition saltsthereof wwith a pharmaceutically acceptable acid
EP1731139A4 (de)	2008-12-03	Pharmazeutische zubereitung vom s/o typ und herstellungsverfahren dafür
IL180513A0 (en)	2007-06-03	Process for synthesis of 4-4'-diamino-diphenyl-sulfone
ZA200501467B (en)	2005-11-30	Process for the synthesis of 1,3-dihydro-2h-3-benzazepin-2-one compounds, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
IL180942A0 (en)	2007-07-04	Synthesis of 6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonic acid amides
IL180311A0 (en)	2007-06-03	Process for the preparation of 4,4-difluoro-3-oxobutanoic acid esters
IL182445A0 (en)	2007-07-24	Process for the preparation of n-(3,5-dichloropyrid-4-yl)-4difluoromethoxy-8-methanesulfona mido-dibenzo[b,d]furan-1-caboxamide
GB0501536D0 (en)	2005-03-02	Product for orally administering a substance
SI1403275T1 (sl)	2006-02-28	Nov postopek sinteze perindoprila in njegovih farmacevtsko sprejemljivih soli
GB0314531D0 (en)	2003-07-30	Process for the preparation of a cosmetic active
SG115741A1 (en)	2005-10-28	New 4-oxo-4,6,7,8-tetrahydro-pyrrolo[1,2-a]pyrazine-6-carboxamide compounds, a process for their preparation and pharmaceutical compositions containing them
SG129412A1 (en)	2007-02-26	New polysubstituted 1,1-pyridylamino-cyclopropanamine compounds, a process for their preparation and pharmaceutical compositions containing them
EP1693067A4 (de)	2008-09-03	Pharmazeutische zusammensetzung gegen herpes, verfahren zur herstellung einer darauf basierenden dosierform und anwendungsverfahren dafür
SI1641438T1 (sl)	2010-10-29	Postopek za pripravo amorfne oblike zdravila
GB0415596D0 (en)	2004-08-18	"Process"
PL1600446T3 (pl)	2008-03-31	Nowe pochodne 3,3-dimetylo-5-cyjano-benzoksepin użyteczne do otrzymywania pochodnych 5-formylo-benzoksepin
IL175282A0 (en)	2006-09-05	Preparation of pharmaceutical salts of [1,4]-bipiperidine
GB0322300D0 (en)	2003-10-22	Process for the preparation of a cosmetic active
WO2008005955A3 (en)	2008-10-09	Synthesis of heterocyclic compounds